CRIS Current Research Information System

MONTI, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 935
NA - Nord America 631
EU - Europa 540
AF - Africa 48
Continente sconosciuto - Info sul continente non disponibili 37
SA - Sud America 36
OC - Oceania 1
Totale 2.228
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 591
IT - Italia 365
VN - Vietnam 345
CN - Cina 178
SG - Singapore 143
HK - Hong Kong 70
BD - Bangladesh 64
FR - Francia 38
NL - Olanda 33
KR - Corea 30
BR - Brasile 29
CA - Canada 26
JP - Giappone 26
DE - Germania 22
ZA - Sudafrica 21
IN - India 18
TH - Thailandia 14
GB - Regno Unito 13
PH - Filippine 12
SE - Svezia 12
FI - Finlandia 11
CI - Costa d'Avorio 9
IE - Irlanda 9
PL - Polonia 9
SC - Seychelles 9
PK - Pakistan 8
AT - Austria 6
CH - Svizzera 5
MX - Messico 5
TR - Turchia 5
TW - Taiwan 5
ID - Indonesia 4
RU - Federazione Russa 4
EC - Ecuador 3
ES - Italia 3
HN - Honduras 3
JM - Giamaica 3
CR - Costa Rica 2
EG - Egitto 2
GH - Ghana 2
IR - Iran 2
LT - Lituania 2
TN - Tunisia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AU - Australia 1
BE - Belgio 1
BG - Bulgaria 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
IQ - Iraq 1
JO - Giordania 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
MA - Marocco 1
MM - Myanmar 1
MY - Malesia 1
OM - Oman 1
PR - Porto Rico 1
PY - Paraguay 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 2.191
Salva come PNG Salva come JPEG
Città #
Singapore 113
Bologna 92
Ho Chi Minh City 86
Hanoi 79
San Jose 74
Hefei 66
Ashburn 62
Hong Kong 59
Council Bluffs 43
Boardman 37
Milan 32
Dallas 30
New York 30
Los Angeles 28
Seoul 27
Chicago 23
Da Nang 22
Lauterbourg 21
Johannesburg 20
Phoenix 19
Tokyo 19
Haiphong 15
Washington 14
Rome 13
Santa Clara 12
Amsterdam 11
Helsinki 11
Munich 10
Parma 10
Abidjan 9
Dublin 9
Modena 9
Florence 8
Imola 8
Lugo 8
Rimini 8
Genoa 7
Hải Dương 7
Treviso 7
Bengaluru 6
Montreal 6
Palermo 6
Philadelphia 6
Polinago 6
São Paulo 6
Vienna 6
Warsaw 6
Bangkok 5
Beijing 5
Brooklyn 5
Buffalo 5
Frankfurt am Main 5
Katy 5
Long Xuyen 5
Naples 5
Reggio Emilia 5
San Diego 5
Shenzhen 5
Bern 4
Cao Lanh 4
Figino 4
Nha Trang 4
Toronto 4
Tân Tiến 4
Bắc Giang 3
Can Tho 3
Castel Maggiore 3
Charlotte 3
Houston 3
Lahore 3
Lanett 3
L’Aquila 3
Mexico City 3
Monticello 3
Mumbai 3
Orem 3
Paris 3
Peshawar 3
Phuket 3
Redondo Beach 3
Secaucus 3
Shanghai 3
Venice 3
Điện Bàn 3
Accra 2
Alexandria 2
Austell 2
Barnet 2
Beverwijk 2
Birmingham 2
Biên Hòa 2
Cache 2
Cairo 2
Castel Bolognese 2
Castelcucco 2
Castelfranco Emilia 2
Cesena 2
City of London 2
Columbia 2
Costabissara 2
Totale 1.377
Salva come PNG Salva come JPEG
Nome #
Gut Microbiome Modulation in Hepatocellular Carcinoma: Preventive Role in NAFLD/NASH Progression and Potential Applications in Immunotherapy-Based Strategies 298
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 255
MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma 238
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response 199
Mir-30e-3p/CXCL3 axis is involved in sorafenib resistance of hepatocellular carcinoma through the modulation of the tumor immune microenvironment 130
Gut microbiome alterations and lenvatinib resistance in hepatocellular carcinoma: the role of Akkermansia muciniphila postbiotics in treatment enhancement 121
miR-30e-3p/CXCL3 axis predicts early tumor escape in sorafenib-treated hepatocellular carcinoma patients. 104
MiR-22-3p targets the G2/M checkpoint inhibitor Wee1 and represents a possible biomarker of TACE response in hepatocellular carcinoma 94
miR-30e-3p/CXCL3 axis predicts early tumor escape in hepatocellular carcinoma patients undergoing sorafenib treatment 91
Towards precision medicine: a preliminary collection of patient-derived organoids for the screening of personalised therapies in hepatocellular carcinoma 87
MiR-22 downregulation activates HIF-1A pathway and induces tumour progression, metabolic reprogramming and sorafenib resistance in hepatocellular carcinoma 86
CXCL3 is a target of miR-30e-3p and predicts tumor escape in sorafenib-treated HCC patients. 82
The tumour suppressor miR-22 induces metabolic reprogramming through GLUT1 targeting and represents a possible biomarker of Sorafenib response in Hepatocellular Carcinoma 82
MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 78
miR-30e-3p/CXCL3 axis predicts early tumor escape in sorafenib-treated HCC patients. 76
MiR-22 regulates HIF-1A pathway and tumor progression and represents a possible biomarker of sorafenib response in hepatocellular carcinoma 72
MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 68
Circulating miR-22 Early Predicts TACE Non-Response and Targets WEE1 in Hepatocellular Carcinoma 67
Totale 2.228
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.768
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20237 0 0 0 0 0 0 0 0 0 0 0 7
2023/202466 6 8 2 11 5 4 3 8 2 5 4 8
2024/2025148 11 9 6 9 5 8 8 3 5 30 27 27
2025/20261.710 90 97 88 64 43 133 237 122 390 95 122 229
2026/2027297 77 66 125 29 0 0 0 0 0 0 0 0
Totale 2.228